H.C. Wainwright raised its price target on CRISPR Therapeutics (CRSP) on August 25, 2025, noting that tariffs related to the Trump era are benefiting AI stocks, and CRSP is held by Cathie Wood.

The entities involved

• CRISPR Therapeutics →

  company in Basel, Switzerland

  Nothing else this week.

• Cathie Wood →

  American investor and businesswoman; CEO of Ark Invest

  • Cathie Wood predicts that Bitcoin's price will reach $2.4 million by 2030.Sun 04:13
  • Cathie Wood's firm, ARK, sold shares of AMD while simultaneously buying shares of Nvidia during August 2024.Fri 06:52
• Donald Trump →

  American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)

  • Trump ended the ceasefire agreement with Iran following recent attacks by Iranian forces.Mon 18:02
  • The Trump administration utilized the Department of Health & Human Services for an AI tool.Mon 18:02

Related events

• Barclays raised its price target for Okta, noting that AI stocks are benefiting from the onshoring trend and Trump-era tariffs.Jun 7
• SharpLink Gaming acquired Ethereum above market prices, causing a stock price drop, while Trump tariffs continue to benefit AI stocks.Jun 7
• Trump-era tariffs are reportedly benefiting certain AI stocks, coinciding with the spin-off of Millrose Properties, Inc. from Lennar Corporation.Jun 8
• AI stocks are benefiting from Trump-era tariffs, and Brian Schwartz maintained an Outperform rating on Workday on September 5th.Jun 7
• Tariffs benefit undervalued AI stocks, and Jim Cramer expressed bullish sentiment regarding Texas Roadhouse.Jun 7